These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7719321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
    Romero JM, Aptsiauri N, Vazquez F, Cozar JM, Canton J, Cabrera T, Tallada M, Garrido F, Ruiz-Cabello F.
    Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
    [Abstract] [Full Text] [Related]

  • 3. Characterization of HLA-G expression in renal cell carcinoma.
    Li BL, Lin A, Zhang XJ, Zhang X, Zhang JG, Wang Q, Zhou WJ, Chen HX, Wang TJ, Yan WH.
    Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
    [Abstract] [Full Text] [Related]

  • 4. HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation.
    Brasanac D, Müller CA, Müller GA, Hadzi-Dzokic J, Markovic-Lipkovski J.
    J Exp Clin Cancer Res; 1999 Dec; 18(4):505-10. PubMed ID: 10746977
    [Abstract] [Full Text] [Related]

  • 5. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
    Ibrahim EC, Guerra N, Lacombe MJ, Angevin E, Chouaib S, Carosella ED, Caignard A, Paul P.
    Cancer Res; 2001 Sep 15; 61(18):6838-45. PubMed ID: 11559559
    [Abstract] [Full Text] [Related]

  • 6. Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.
    Hanak L, Slaby O, Lauerova L, Kren L, Nenutil R, Michalek J.
    Med Sci Monit; 2009 Dec 15; 15(12):CR638-43. PubMed ID: 19946235
    [Abstract] [Full Text] [Related]

  • 7. Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.
    Sáenz-López P, Gouttefangeas C, Hennenlotter J, Concha A, Maleno I, Ruiz-Cabello F, Cózar JM, Tallada M, Stenzl A, Rammensee HG, Garrido F, Cabrera T.
    Tissue Antigens; 2010 Feb 15; 75(2):110-8. PubMed ID: 19912575
    [Abstract] [Full Text] [Related]

  • 8. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J, Rebmann V, Grosse-Wilde H, Luboldt H, Ruebben H, Drexler I, Sutter G, Huber C, Seliger B.
    Cancer Res; 2003 Jul 15; 63(14):4107-11. PubMed ID: 12874014
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D, Marković-Lipkovski J, Hadzi-Djokić J, Müller GA, Müller CA.
    Neoplasma; 1999 Jul 15; 46(3):173-8. PubMed ID: 10613593
    [Abstract] [Full Text] [Related]

  • 10. Antigen expression in renal cell carcinoma. Correlation with histological grade, pathological stage and development of distant metastasis.
    Reuter VE.
    Eur Urol; 1990 Jul 15; 18 Suppl 2():4-5. PubMed ID: 2226607
    [No Abstract] [Full Text] [Related]

  • 11. Immunohistochemical studies on the expression of HLA class I antigens in renal cell carcinoma: comparison of primary and metastatic tumor tissue.
    Buszello H, Ackermann R.
    Eur Urol; 1994 Jul 15; 25(2):158-63. PubMed ID: 8137858
    [Abstract] [Full Text] [Related]

  • 12. [Immunohistochemical characterization of renal cell carcinomas].
    Bohle B, Waldherr R, Schwechheimer K, Moldenhauer G, Momburg F.
    Verh Dtsch Ges Pathol; 1986 Jul 15; 70():274-8. PubMed ID: 3825252
    [No Abstract] [Full Text] [Related]

  • 13. HLA class I and II antigens expression in patients with renal cell carcinoma.
    Ozgur BC, Gonenc F, Yazicioglu AH.
    Saudi J Kidney Dis Transpl; 2009 Jan 15; 20(1):97-101. PubMed ID: 19112225
    [Abstract] [Full Text] [Related]

  • 14. Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma.
    Luboldt HJ, Kubens BS, Rübben H, Grosse-Wilde H.
    Cancer Res; 1996 Feb 15; 56(4):826-30. PubMed ID: 8631020
    [Abstract] [Full Text] [Related]

  • 15. Immunophenotypic markers in renal cell carcinoma.
    Banner BF, Burnham JA, Bahnson RR, Ernstoff MS, Auerbach HE.
    Mod Pathol; 1990 Mar 15; 3(2):129-34. PubMed ID: 1691492
    [Abstract] [Full Text] [Related]

  • 16. HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma.
    Komohara Y, Harada M, Ishihara Y, Suekane S, Noguchi M, Yamada A, Matsuoka K, Itoh K.
    Oncol Rep; 2007 Dec 15; 18(6):1463-8. PubMed ID: 17982631
    [Abstract] [Full Text] [Related]

  • 17. Circulating cancer cells in renal-cell carcinoma.
    Pontes JE, Pescatori E, Connelly R, Hashimura T, Tubbs R.
    Prog Clin Biol Res; 1990 Dec 15; 348():1-12. PubMed ID: 2385602
    [No Abstract] [Full Text] [Related]

  • 18. Expression of major histocompatibility complex (MHC) antigens and their loss on culture in renal carcinoma.
    Angus R, Collins CM, Symes MO.
    Eur J Cancer; 1993 Dec 15; 29A(15):2158-60. PubMed ID: 8297657
    [Abstract] [Full Text] [Related]

  • 19. Establishment and characterization of human renal cancer cell lines and autologous normal kidney short term cultures.
    Schattka S, Decken K, Schmitz-Dräger B, Ackermann R, Ebert T.
    Investig Urol (Berl); 1994 Dec 15; 5():35-41. PubMed ID: 7719318
    [No Abstract] [Full Text] [Related]

  • 20. Structure, expression and function of HLA-G in renal cell carcinoma.
    Seliger B, Schlaf G.
    Semin Cancer Biol; 2007 Dec 15; 17(6):444-50. PubMed ID: 17707652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.